11，OKeefe JH, Kim SC,Hall RR, et al. Estrogen replacement after coronary angioplasty in women. J Am CollCardiol, 1997,29:15
22，Tilly-Kiesi M, Kahri J, Pyorala T, et al. Responses of HDL subclasses, Lp(A-I） andLp(a-I：A-Ⅱ) levels and lipolytic enzyme activities to continuous oralestrogen-progestin and transdermal estrogen with cyclic progestin regimens inpostmenopausal women. Athersclerosis, 1997,129:249～259
33，Folsom AR, Mc Grovem PG, Nabulsi A A, et al. Change in plasma lipids and lipoproteinsassociated with starting or stopping postmenopausal hormone replacement therapy. Am HeartJ, 1996,132:952～958
44，Losordo DW, Kearmey M, Kim EA, et al. Variable expression of the estrongen receptor innormal and atherosclerosic coronary arteries of premenopasual women. Circulation,1994,89:1501～1510
56，Chen Yuan, Zhou Mei, Liu Uili, et al. Lipoperoxidative damage in patients withcoronary heart disease. Med Sci Res, 1988,16:1059～1060
67，Ren S, Man RY, Angel A, et al. Oxidative modification enhances lipoprotein(a)-inducedoverproduction of plasminogen activator inhibitor-1 in cultured vascular endothelialcells. Atheroslerosis, 1997,128:1～10
78，R.H.Knopp. Effects of estrogen on lipid metabolism and cardiovascular disease inwoman. Atherosclerosis, 1994,110(suppl):S83～91
8Zavaroni I,Bonini L,Gasparini P.Hyperinsulinmia in a normal population as a predictor of non-insulin-dependent diabetes mellitus,hypertension, and coronary heart disease: the barilla factory revisited[].Metabolism.1999
9Kip KE,Faxon DP,Detre KM,et al.Coronary angioplasty in diabetic patients : the national heart, lung, and blood institute percutaneous transluminal coronary angioplasty registry[].Circulation.1996
10Haffner SM.Cardiovascular risk factors and the prediabetic symdrome[].Annals of Medicine.1996
